EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The dichotomous roles of microbial-modified bile acids 7-oxo-DCA and isoDCA in intestinal tumorigenesis

Xingchen Dong, Fei Sun, Henry Secaira-Morocho, Alisa Hui iD, Ke Wang iD, Chunmiao Cai iD, Shirsa Udgata, Brian Low, Songlin Wei iD, Xinyi Chen iD, Ming Qi, Cheri A Pasch iD und 6 weitere

Proceedings of the National Academy of Sciences · 19.11.2024 · 121 (47)

DOI: 10.1073/pnas.2317596121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 12.11.2024. Verfasst von Xingchen Dong und 17 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin-Madison, Madison, WI 53705. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Carcinogenesis. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: UW fall competition support from Wisconsin Alumni Research Foundation, PhRMA foundation Faculty Starter Grant, Univeristy of Wisconsin-Madison.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gut microbiota has a significant impact on the development and function of intestinal epithelial cells (IECs) by modifying bile acid (BA) metabolites. Recently, specific gut microbiome-derived BAs, such as 7-oxo-deoxycholic acid (7-oxo-DCA) and isodeoxycholic acid (isoDCA), have been identified to be shifted inversely in colitis and hepatic liver diseases. Although the responsible gut microbes have been identified, metabolites’ effects on IECs remain largely unclear. We found that although high-fat diet treatment in mice elevated both 7-oxo-DCA and isoDCA levels, during intestinal tumorigenesis, 7-oxo-DCA levels rise while isoDCA levels decrease. Interestingly, 7-oxo-DCA promotes cancer cell growth, while isoDCA suppresses it. Moreover, 7-oxo-DCA promotes whereas isoDCA inhibits the proliferation of intestinal stem cells in organoids derived from WT and APC Min/+ mice, as well as in patient-derived colon cancer organoids. The APC Min/+ mice administered with 7-oxo-DCA heightened gut permeability and increased tumor burden, whereas isoDCA protected gut barrier and reduced tumor loads. Both BAs reshape the BA pool and shifted gut microbiome. Mechanistically, we identified 7-oxo-DCA as a natural antagonist of Farnesoid X Receptor (FXR) to downregulate FXR signaling, as opposed to isoDCA, which is a potent FXR agonist to upregulate FXR signaling. In conclusion, we unveiled the opposing roles of 7-oxo-DCA and isoDCA to promote or inhibit intestinal tumorigenesis, respectively. Manipulating the BA–FXR axis during tumor initiation and progression holds great promise for developing innovative diagnostic and therapeutic approaches for the treatment of colorectal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeCarcinogenesisAnimalsMiceHumansBile Acids and SaltsDeoxycholic AcidIntestinal MucosaCell ProliferationDiet, High-FatReceptors, Cytoplasmic and NuclearMice, Inbred C57BLOrganoidsColonic NeoplasmsReceptor, Farnesoid X-Activated

Stichwörter der Autor:innen

bile acidscolorectal cancernuclear receptor FXR

Substanzen

Bile Acids and SaltsDeoxycholic AcidReceptors, Cytoplasmic and NuclearReceptor, Farnesoid X-Activated

Autor:innen und Institutionen

  • Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin-Madison, Madison, WI 53705.
  • School of Life Science, Arizona State University, Tempe, AZ 85287.
  • Department of Chemistry, University of British Columbia, Vancouver, BC V6T 1Z1, Canada.
  • Division of Hematology and Oncology, Department of Medicine, University of Wisconsin-Madison, Madison, WI 53705.
  • McArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin-Madison, Madison, WI 53705.
  • School of Medicine and Public Health, University of Wisconsin Carbone Cancer Center, Madison, WI 53792.

ORCID-Profile: Alisa Hui, Ke Wang, Chunmiao Cai, Songlin Wei, Xinyi Chen, Cheri A Pasch, Jiaoyang Jiang, Tao Huan

Förderung

  • UW fall competition support from Wisconsin Alumni Research Foundation
  • PhRMA foundation Faculty Starter Grant
  • Univeristy of Wisconsin-Madison
  • NCI NIH HHS
  • Margaret Q. Landenberger Research Foundation (The Margaret Q. Landenberger Research Foundation)
  • American Cancer Society (ACS)

Zitieren

APA

Dong, X., Sun, F., Secaira-Morocho, H., Hui, A., Wang, K., Cai, C., Udgata, S., Low, B., Wei, S., Chen, X., Qi, M., Pasch, C. A., Xu, W., Jiang, J., Zhu, Q., Huan, T., Deming, D. A., & Fu, T. (2024). The dichotomous roles of microbial-modified bile acids 7-oxo-DCA and isoDCA in intestinal tumorigenesis. Proceedings of the National Academy of Sciences, 121(47). https://doi.org/10.1073/pnas.2317596121

Vancouver

Dong X, Sun F, Secaira-Morocho H, Hui A, Wang K, Cai C, et al. The dichotomous roles of microbial-modified bile acids 7-oxo-DCA and isoDCA in intestinal tumorigenesis. Proceedings of the National Academy of Sciences. 2024;121(47). doi:10.1073/pnas.2317596121

BibTeX
@article{Dong2024,
  author = {Dong, Xingchen and Sun, Fei and Secaira-Morocho, Henry and Hui, Alisa and Wang, Ke and Cai, Chunmiao and Udgata, Shirsa and Low, Brian and Wei, Songlin and Chen, Xinyi and Qi, Ming and Pasch, Cheri A and Xu, Wei and Jiang, Jiaoyang and Zhu, Qiyun and Huan, Tao and Deming, Dustin A and Fu, Ting},
  title = {The dichotomous roles of microbial-modified bile acids 7-oxo-DCA and isoDCA in intestinal tumorigenesis},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  volume = {121},
  number = {47},
  doi = {10.1073/pnas.2317596121}
}
Kostenlos starten →